Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.40B | 3.51B | 4.42B | 4.28B | 2.79B | Gross Profit |
647.60M | 716.50M | 1.13B | 1.03B | 496.70M | EBIT |
407.60M | 467.80M | 827.50M | 698.20M | 282.40M | EBITDA |
360.00M | 511.90M | 831.70M | 695.20M | 281.60M | Net Income Common Stockholders |
219.60M | 349.00M | 643.60M | 555.50M | 217.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
647.40M | 764.90M | 952.30M | 921.00M | 823.00M | Total Assets |
6.29B | 6.25B | 6.48B | 6.24B | 5.75B | Total Debt |
121.00M | 126.80M | 115.50M | 111.40M | 131.60M | Net Debt |
-526.40M | -638.10M | -836.80M | -809.60M | -691.40M | Total Liabilities |
1.89B | 1.73B | 1.98B | 1.93B | 1.73B | Stockholders Equity |
4.41B | 4.52B | 4.50B | 4.31B | 4.02B |
Cash Flow | Free Cash Flow | |||
189.60M | 122.70M | 475.40M | 427.30M | -309.20M | Operating Cash Flow |
193.00M | 129.60M | 477.50M | 431.90M | -301.20M | Investing Cash Flow |
45.80M | 27.40M | 33.60M | -10.30M | -23.90M | Financing Cash Flow |
-352.30M | -342.80M | -482.40M | -321.70M | 516.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £4.41B | 16.47 | 7.71% | 2.91% | 15.42% | 4.45% | |
74 Outperform | £4.23B | 11.81 | 11.03% | 1.54% | 0.39% | -17.64% | |
72 Outperform | £4.28B | 19.50 | 4.92% | 7.70% | -3.22% | -37.21% | |
68 Neutral | £2.14B | 30.29 | 2.27% | ― | 6.04% | -66.96% | |
64 Neutral | £3.41B | 23.23 | 4.22% | 1.46% | -11.63% | -31.81% | |
63 Neutral | £6.70B | 44.92 | 1.81% | 2.38% | 4.78% | -53.59% | |
62 Neutral | $6.86B | 11.07 | 2.77% | 4.27% | 2.66% | -24.95% |